Zhejiang Tianyu Pharmaceutical Co., Ltd.

Zhejiang Tianyu Pharmaceutical Co., Ltd. saw a significant rise on July 1, 2026, contrasting with the modest gain of the China Shanghai Composite. Despite recent increases, the company faces long-term challenges, including a notable decline over the past year and five years, with a market capitalization of CNY 3,984 million.

Zhejiang Tianyu Pharmaceutical Co., Ltd. saw a significant increase in its stock today, reaching an intraday high. The company has performed well over the past week and month, but faces challenges with its longer-term performance. Financial metrics indicate a relatively high valuation and a modest dividend yield.

Zhejiang Tianyu Pharmaceutical Co., Ltd. saw a significant increase in its stock price today, contrasting with a decline in the China Shanghai Composite index. Despite this short-term gain, the company has struggled over the past year, with a notable drop in performance and relatively high valuation metrics.

Zhejiang Tianyu Pharmaceutical Co., Ltd. saw a notable increase in its stock performance on May 25, 2026, reaching an intraday high. While the company has outperformed the Shanghai Composite index recently, it faces long-term growth challenges, including a decline in operating profit and modest net sales growth.

Zhejiang Tianyu Pharmaceutical Co., Ltd. has recently experienced an evaluation adjustment, highlighting its performance metrics and market position. The company reported a 22.92% increase in net sales and a 12.78% rise in net profit for the latest quarter, showcasing consistent growth over two consecutive quarters.

Zhejiang Tianyu Pharmaceutical Co., Ltd. saw a significant rise in stock price on March 27, 2026, outperforming the broader market. The company reported a 22.92% increase in net sales and a 12.78% rise in net profit for the first half of the year, despite long-term performance challenges.